Drug Topics e-News:
Having trouble viewing this email? View in a browser.
|
You are subscribed to %%list.name%% as %%emailaddr%%. Unsubscribe.

|
to Drug Topics e-News
|
|
|
|
 |
 |
Newest: Creating an informational home pharmacy |
For pharmacists, from Drug Topics: Continuing education for pharmacists and pharmacy technicians. Go to CE site here |
|
|
Survey
This month we would like to know...
Have you ever reached into your own pocket to help a patient pay for a prescription?
• Never
• Once
• A few times
• Several times
• Frequently
|
|
|
Despite a drop in the number of prescriptions written for the top 10 branded drugs in 2010 compared with 2009, there were gains in terms of retail dollars among most of the manufacturers of the top 10 products, according to the Drug Topics top 200 branded drugs lists.
To view the top 200 branded and generic drug lists,
click here. |
 |
|
 |
A discussion generated by
Drug Topics’ readers, editorial staff, and advisory board
David Stanley is a practicing community pharmacist in California and frequent contributor to Drug Topics. |
The weirdest wellness strategy ever. Read full article.
 |
The battle against illegal drug promotion continues. The latest culprit is Novo Nordisk, which agreed to pay $25 million to settle civil liabilities over off-label promotion for its hemostasis drug NovoSeven (recombinant factor VIIa) on June 10. Read full article.
 |
NEW YORK (Reuters Health) - The estimated 10-year risk for coronary heart disease (CHD) among adults with diabetes has declined significantly in the past decade, U.S. data show. Read full article.
 |
NEW YORK (Reuters Health) - In patients with ulcerative colitis (UC) and primary sclerosing cholangitis (PSC), high doses of ursodeoxycholic acid (UDCA) are associated with an increased risk of colorectal neoplasia, a new study shows. Read full article.
 |
NEW YORK (Reuters Health) - Men who use inhaled anticholinergics for chronic obstructive pulmonary disease (COPD) have an increased risk of urinary retention, according to a new report. Read full article.
 |
CDER recently announced that it will elevate the Office of Compliance to a Super Office to continue to ensure the safety, quality, and integrity of drugs in America, according to a memo from CDER Director Janet Woodcock. Read full article. |
 |
Community pharmacists and medication therapy management can play a much greater role in Accountable Care Organizations, pharmacists' organizations said in new comments to the Centers for Medicare and Medicaid Services. Read full article. |
 |
Meetings and Events
June 25-28, 2011 NACDS Marketplace Conference
Boston
Contact:
P.O. Box 34814
Alexandria, VA 22334-0814
[email protected]
July 22-25, 2011 NPhA Annual Convention
Atlanta
Contact:
107 Kilmayne Drive, Suite C
Cary, NC 27511
Phone: 404-262-3344
Fax: 404-262-8689
August 27-30, 2011 NACDS Pharmacy & Technology Conference
Boston
Contact:
P.O. Box 34814
Alexandria, VA 22334-0814
703-683-5678
October 6-7 NCPA Diabetes Accreditation
Standards-Practical Applications (DASPA)
Nashville, TN
Contact:
100 Daingerfield Road
Alexandria, VA 22314
800-544-7447
|
|
|
|
Contact Us |
Contact a Drug Topics editor Click Here
Contact a Drug Topics sales representative Click Here
Learn about direct mail, reprints and classifieds in Drug Topics Click Here |
You are subscribed to %%list.name%% as %%emailaddr%%. Click here to unsubscribe or edit your member profile.
To ensure delivery to your inbox, please add us to your address book. If you need help doing this, Click here.
Advanstar Communications provides certain customer contact data (such as customers' names, addresses, phone numbers and e-mail addresses) to third parties who wish to promote relevant products, services and other opportunities which may be of interest to you. If you do not want Advanstar Communications to make your contact information available to third parties for marketing purposes, simply call (toll free) 866-529-2922 at any time, or
fax us at 218-740-6417. Outside the U.S., please phone 218-740-6395. Contact us by mail at Advanstar Communications Inc., 131 West First St., Duluth, MN 55802-2065, USA.
|
|